SKIN CANCER
RESEARCH STUDY

Cutaneous Squamous Cell Carcinoma in situ

Millions of Americans are diagnosed with Squamous Cell Carcinoma in situ of the skin, the second most common form of skin cancer. It is characterized by abnormal, accelerated growth of the squamous cells.

Dermatologists are hard at work to identify and improve treatments to manage various forms of skin cancer, however, support from people diagnosed with this disease is needed to help current and future generations to come.

Our Study

We are conducting a research study in our area to evaluate the safety and efficacy of an investigational medication for adults with a confirmed diagnosis of Squamous Cell Carcinoma in situ of the skin.

Locations in Hackensack NJ, Scottsdale AZ and West Palm Beach FL

Participation Requirements

In order to participate, you must have been diagnosed with Squamous Cell Carcinoma in situ on your body (non-genital, facial or scalp) within the last 6 months.

Qualified Participants May Receive:

Surgical excision at no cost
Investigational treatment at no cost
Possible compensation for their time

Please complete the fields below so the research coordinator may contact you.

Please enter first name.

Please enter last name.

Please enter valid email.

Please enter valid mobile number.

Please enter valid zip code.

Your privacy is important to us. By clicking "Submit" you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.